Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.51
+0.05 (0.74%)
May 6, 2026, 3:19 PM EDT - Market open

Precision BioSciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-43.6-45.727.17-61.32-111.64-30.6
Depreciation & Amortization
1.371.473.46.827.88.98
Stock-Based Compensation
8.9110.1912.614.0419.216.51
Other Adjustments
8.95-2.53-27.62-2.1714.78-25.33
Change in Receivables
-40.230.67-0.18-0.239.51
Changes in Accounts Payable
0.02-0.74-2.11.510.150.87
Changes in Unearned Revenue
-26.23-26.26-58.86-43.9527.366.84
Changes in Other Operating Activities
-3.59-2.486.291.13-3.172.37
Operating Cash Flow
-58.73-65.84-58.45-84.11-45.75-10.85
Capital Expenditures
-0.04-0.09-0.25-1.96-3.32-5.05
Sale of Property, Plant & Equipment
0.070.070.060.11--
Purchases of Intangible Assets
-0.47-0.62-0.03-0.32--0.75
Proceeds from Business Divestments
---8--
Investing Cash Flow
-0.43-0.63-0.225.83-3.32-5.8
Short-Term Debt Issued
----19.812.51
Short-Term Debt Repaid
---22.51---
Net Short-Term Debt Issued (Repaid)
---22.51-19.812.51
Long-Term Debt Issued
--22.47--2.47
Long-Term Debt Repaid
------2.5
Net Long-Term Debt Issued (Repaid)
--22.47---0.04
Issuance of Common Stock
77.8195.1650.495.3975.1868.06
Net Common Stock Issued (Repurchased)
77.8195.1650.495.3975.1868.06
Other Financing Activities
------0.01
Financing Cash Flow
85.2295.1650.455.3994.9970.52
Net Cash Flow
26.0628.69-8.21-72.945.9153.87
Free Cash Flow
-58.77-65.93-58.7-86.07-49.07-15.91
FCF Margin
-130.38%-192.41%-85.44%-176.64%-195.52%-13.77%
Free Cash Flow Per Share
-3.53-5.14-8.53-22.41-16.75-8.13
Levered Free Cash Flow
56.43-73.81-44.39105.95-63.01-14.13
Unlevered Free Cash Flow
100.7592.55112.04104.74141.33284.43
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q